Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hematologic Neoplasms 3Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Graft vs Host Disease 2Ganglioneuroblastoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Teratoma 1Recurrence 1Neuroblastoma 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Mast-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia 1High Risk Myeloid Malignancies 1GATA2 Deficiency 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Etoposide 2Carboplatin 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Standard of Care 1Second-Look Surgery 1Respiratory Physiological Phenomena 1Reoperation 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cisplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Embryonal × Thiotepa × 90 days × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡